Home › Tricuspid Valve Insufficiency
Tricuspid Valve Insufficiency clinical trials recruiting in the U.S.
19 studies for Tricuspid Valve Insufficiency are recruiting participants at sites across the United States.
Cities with the most studies
- New York City, NY9 studies
- Atlanta, GA7 studies
- Cincinnati, OH6 studies
- The Bronx, NY6 studies
- Chicago, IL5 studies
- Nashville, TN5 studies
- Portland, OR4 studies
- Cleveland, OH4 studies
- Minneapolis, MN4 studies
- Philadelphia, PA4 studies
- Thousand Oaks, CA4 studies
- Seattle, WA4 studies
- Rochester, MN4 studies
- Phoenix, AZ3 studies
- Los Angeles, CA3 studies
- New Rochelle, NY3 studies
By state
- Arizona4 studies
- California11 studies
- Georgia7 studies
- Illinois5 studies
- Michigan3 studies
- Minnesota8 studies
- New York12 studies
- Ohio9 studies
- Oregon4 studies
- Pennsylvania5 studies
- Tennessee5 studies
- Texas3 studies
- Washington4 studies
Recently updated studies
TTVR STRONG Under Coverage With Evidence Development (CED) Study
RecruitingObservational study
Ages 65 and older · All sexes · Updated Sep 29, 2026 · NCT06833476EFS of the DUO System for Tricuspid Regurgitation
Recruiting
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05913908Early Feasibility Study (EFS) Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System
Recruiting
Ages 18 to 90 · All sexes · Updated Sep 25, 2026 · NCT06183684Transcatheter Tricuspid Valve Replacement With the Medtronic Intrepid™ Transcatheter Tricuspid Valve Replacement (TTVR) System in Severe Tricuspid Regurgitation
Recruiting
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07321899Clinical Safety and Efficacy of the VDyne Transcatheter Tricuspid Valve Replacement System for the Treatment of Tricuspid Regurgitation ( VISTA-US)
Recruiting
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05848284Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT06033274Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
Recruiting
Ages 18 and older · All sexes · Updated Sep 14, 2026 · NCT04097145Home-Based Cardiac Rehabilitation Using a Novel Mobile Health Exercise Regimen Following Transcatheter Heart Valve Interventions
Recruiting
Ages 18 and older · All sexes · Updated Sep 4, 2026 · NCT06077201A Post-Market Assessment of the Safety and Performance of the TriClip™ System
RecruitingObservational study
Ages 18 and older · All sexes · Updated Sep 2, 2026 · NCT07586995Pivotal Trial to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System (The TRINITY Pivotal Trial)
Recruiting
Ages 21 and older · All sexes · Updated Aug 28, 2026 · NCT07454980VDyne Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
Recruiting
Ages 18 and older · All sexes · Updated Aug 17, 2026 · NCT07516444The TRICURE EFS Study
Recruiting
Ages 18 and older · All sexes · Updated Jul 23, 2026 · NCT06506942Clinical Study of the inQB8 TTVR System (The MonarQ Study)
Recruiting
Ages 18 and older · All sexes · Updated May 18, 2026 · NCT06611579DELINEATE-Prospective
RecruitingObservational study
Ages 18 and older · All sexes · Updated Apr 16, 2026 · NCT07197736Trisol System EFS Study
Recruiting
Ages 18 and older · All sexes · Updated Nov 21, 2025 · NCT04905017CorMatrix Cor TRICUSPID ECM Valve Replacement - Pivotal Study
Recruiting
All ages · All sexes · Updated Sep 2, 2025 · NCT05742906TriClip CED RWE Study
RecruitingObservational study
Ages 18 and older · All sexes · Updated Aug 11, 2025 · NCT06920745Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
Recruiting
Ages 18 to 85 · All sexes · Updated Mar 7, 2025 · NCT06212193Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
Recruiting
Ages 18 and older · All sexes · Updated Feb 23, 2021 · NCT02537769From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.